Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityNo recent work listed

Justin S. Hanes

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9672-9821; OpenAlex author ID A5041922458; NIH RePORTER profile ID 7741516. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
1
Labs led
0
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 grant

Papers 2

  1. Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer. Co-author DOI 10.1002/pmic.201800451↗
  2. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. Co-author DOI 10.1073/pnas.1611406113↗

Grants 1

  1. Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy R01CA193895↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anne Le · 2 shared papers, 1 shared grant, 2016–2020 · strength 0.49
  2. Barbara Stauch Slusher · 2 shared papers, 1 shared grant, 2016–2020 · strength 0.49
  3. Amira Elgogary · 2 shared papers, 2016–2019 · strength 0.12
  4. Jie Fu · 2 shared papers, 2016–2019 · strength 0.12
  5. Sunag Udupa · 1 shared paper, 2019 · strength 0.07
  6. Sarah Zimmermann · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.